Science Explorer Back to mapMap
Discussion
Researcher · Bayer (Germany) · Germany

Ulrich Lücking

Ulrich Lücking publishes mostly in Organic Chemistry, Molecular Biology and Oncology, on topics such as Synthesis and Catalytic Reactions, Click Chemistry and Applications and Cancer-related Molecular Pathways.

ORCID 0000-0003-2466-5800 OpenAlex
World rank
#288,689
of 7,710,434 ranked researchers
Rank in Germany
#14,474
of 364,343
Works
100
Citations
3.7k
Citations per work
37.4
h-index
24
i10-index 30Top 16% in Organic Chemistry
Ulrich Lücking

What does Ulrich Lücking research?

Ulrich Lücking's work is mostly in Chemistry (29%), Biochemistry, Genetics and Molecular Biology (24%), Medicine (22%).

Physical Sciences: 29 works · 28.7% of their workChemistry: 29 works · 28.7% of their workOrganic Chemistry: 29 works · 28.7% of their workEverything else: 25 works · 25.1% of their workLife Sciences: 24 works · 24.0% of their workBiochemistry, Genetics and Molecular Biology: 24 works · 24.0% of their workMolecular Biology: 22 works · 21.6% of their workCancer Research: 2 works · 2.4% of their workHealth Sciences: 22 works · 22.2% of their workMedicine: 22 works · 22.2% of their workOncology: 14 works · 13.8% of their workPulmonary and Respiratory Medicine: 6 works · 6.0% of their workEpidemiology: 2 works · 2.4% of their workTHEIR WORKUlrich Lücking100works
Life Sciences24%Physical Sciences29%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Chemistry2928.7%
  2. Everything else2525.1%
    1. Biochemistry, Genetics and Molecular Biology2424.0%
    1. Medicine2222.2%
  1. 1Organic Chemistry29% of their works
  2. 2Molecular Biology22% of their works
  3. 3Oncology14% of their works
  4. 4Pulmonary and Respiratory Medicine6% of their works
  5. 5Cancer Research2% of their works
  6. 6Epidemiology2% of their works

Research topics

Which keywords describe Ulrich Lücking's research?

The keywords of their largest research topics: Medicinal Chemistry, Amination, Catalytic, Cancer Therapy, Click Chemistry, Copper-Catalyzed Cycloaddition, Cell Cycle and p53.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Medicinal Chemistry212 topics
  2. Amination161 topic
  3. Catalytic161 topic
  4. Cancer Therapy142 topics
  5. Click Chemistry101 topic
  6. Copper-Catalyzed Cycloaddition101 topic
  7. Cell Cycle91 topic
  8. p5391 topic
  9. BRCA Mutation51 topic
  10. Breast Cancer51 topic
  11. CDK4/6 Inhibitors51 topic
  12. DNA51 topic
  13. Glycosidase Inhibitors51 topic
  14. Oligosaccharide Synthesis51 topic
  15. PARP Inhibitors51 topic
  16. Sulfur Bond Formation51 topic
  17. Topoisomerases51 topic
  18. Transition-Metal-Catalyzed51 topic

Where does Ulrich Lücking work?

Ulrich Lücking's main affiliation in the publication record is Bayer (Germany), Germany.

How many publications and citations does Ulrich Lücking have?

OpenAlex counts 100 works and 3,735 citations for Ulrich Lücking, an h-index of 24, ranking #288,689 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ulrich Lücking. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.